These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12771482)

  • 1. Short-contact therapy with tazarotene in psoriasis vulgaris.
    Veraldi S; Schianchi R
    Dermatology; 2003; 206(4):347-8. PubMed ID: 12771482
    [No Abstract]   [Full Text] [Related]  

  • 2. Short contact therapy with tazarotene in psoriasis vulgaris.
    Veraldi S; Caputo R; Pacifico A; Peris K; Soda R; Chimenti S
    Dermatology; 2006; 212(3):235-7. PubMed ID: 16549919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the potential clinical benefits of switching patients with plaque psoriasis from calcipotriene to tazarotene treatment.
    Coynik D
    Cutis; 2000 Dec; 66(6 Suppl):19-24. PubMed ID: 11147087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medication of the month. Tazarotene 0.05%-0.1% (Zorac)].
    Henno A; Hua MT; de la Brassinne M
    Rev Med Liege; 2003 Nov; 58(11):706-8. PubMed ID: 14748200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatment options for psoriasis.
    McClelland PB
    Dermatol Nurs; 1997 Oct; 9(5):295-304; quiz 305-6. PubMed ID: 9392761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An observation study evaluating the treatment of plaque psoriasis with tazarotene gels, alone and with an emollient and/or corticosteroid.
    Tanghetti EA;
    Cutis; 2000 Dec; 66(6 Suppl):4-11. PubMed ID: 11147088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obtaining the optimal treatment outcome with tazarotene.
    McClelland PB
    Dermatol Nurs; 1998 Oct; 10(5):343-8. PubMed ID: 9873273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical tazarotene vs. coal tar in stable plaque psoriasis.
    Kumar U; Kaur I; Dogra S; De D; Kumar B
    Clin Exp Dermatol; 2010 Jul; 35(5):482-6. PubMed ID: 19874376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.
    Chandraratna RA
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S12-7. PubMed ID: 9270551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging.
    Roeder A; Schaller M; Schäfer-Korting M; Korting HC
    Skin Pharmacol Physiol; 2004; 17(3):111-8. PubMed ID: 15087589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of improvement in psoriasis after treatment with tazarotene 0.1% gel plus clobetasol propionate 0.05% ointment: comparison of maintenance treatments.
    Lebwohl M; Lombardi K; Tan MH
    Int J Dermatol; 2001 Jan; 40(1):64-6. PubMed ID: 11277960
    [No Abstract]   [Full Text] [Related]  

  • 12. Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study.
    Bianchi L; Soda R; Diluvio L; Chimenti S
    Br J Dermatol; 2003 Jul; 149(1):207-9. PubMed ID: 12890227
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prescribe topical treatments for psoriasis].
    Lorette G; Fontès V
    Rev Prat; 2004 Jan; 54(1):40-2. PubMed ID: 15049598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study.
    Huang YC; Chou CL; Chiang YY
    Lasers Surg Med; 2013 Feb; 45(2):102-7. PubMed ID: 23423871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tazarotene--a topical retinoid for psoriasis.
    Drug Ther Bull; 1999 Jun; 37(6):47-8. PubMed ID: 10692712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An observation study evaluating the efficacy of tazarotene plus corticosteroid in treating plaque psoriasis in patients switched from treatment with calcipotriene +/- corticosteroid.
    Tanghetti EA;
    Cutis; 2000 Dec; 66(6 Suppl):12-8. PubMed ID: 11147086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood nail psoriasis: a useful treatment with tazarotene 0.05%.
    Diluvio L; Campione E; Paternò EJ; Mordenti C; El Hachem M; Chimenti S
    Pediatr Dermatol; 2007; 24(3):332-3. PubMed ID: 17542899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tazarotene therapy for psoriasis, acne vulgaris, and photoaging.
    Guenther LC
    Skin Therapy Lett; 2002 Mar; 7(3):1-4. PubMed ID: 12007011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New topicals for mild and moderate psoriasis.
    Cooper CW
    JAAPA; 1999 Apr; 12(4):52-4, 57-60. PubMed ID: 10728082
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic profile of tazarotene.
    Duvic M
    Cutis; 1998 Feb; 61(2 Suppl):22-6. PubMed ID: 9787988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.